Dr. R L Madhusudhan

Bangalore, Karnataka

Diabetologist | MBBS, MD

Highly motivated and results-oriented Principal Investigator (PI) with 20 years of experience in conducting clinical trials across various therapeutic areas and first in human trials. Possesses a strong understanding of research methodologies, GCP guidelines, and regulatory requirements. Proven ability to manage all aspects of clinical trials, from protocol development to patient recruitment and data analysis. Eager to contribute expertise to advance medical research and improve patient care. Higher Education Adichunchanagiri Institute of Medical sciences (AIMS)​​​​1997 to 2003 ​​​​​ Recognized by Medical Council of India ​​​​​ Bachelor’s in medicine and Bachelor in Surgery, M.B.B.S. Additional Education: Fellowship in Diabetology (Indian Medical Association) Postgraduate in Diabetology (Johns Hopkins University School of Medicine, USA) Postgraduate program in Advance Diabetology (Diabetes UK) Publications • Malaria vaccine candidate based on Duffy-binding protein elicits strain transcending functional antibodies in a Phase I trial www.nature.com/npjvaccines • A phase-I, open label clinical trial to assess the safety & tolerability of qHPV vaccine manufactured by Serum Institute of India Pvt. Ltd. In adults. www.elsevier.com/locate/jvacx ​ • A phase-I, open label clinical trial to assess the safety of Tdap vaccine manufactured by Serum Institute of India Pvt. Ltd. in adults. www.elsevier.com/locate/jvacx • Safety and tolerability of a liquid bovine rotavirus pentavalent vaccine (LBRV-PV) in adults. www.elsevier.com/locate/jvacx